Aduro Biotech Presents Preclinical Data Supporting Clinical Development of its Anti-APRIL Antibody, BION-1301, for the Treatment of Multiple Myeloma

Dec 03, 2016 17:00 pm UTC| Business

BERKELEY, Calif. and OSS, The Netherlands, Dec. 03, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced the presentation of data from...

Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting

Dec 03, 2016 16:00 pm UTC| Business

Together, all nine participants have reduced infusions of factor IX concentrates by 99 percent over cumulative 1,650 days ...

Atara Bio Announces Results from Ongoing Phase 2 Trial of Allogeneic Cytomegalovirus (CMV)-specific Cytotoxic T Lymphocytes (CTL) at the American Society of Hematology (ASH) Annual Meeting 2016

Dec 03, 2016 15:30 pm UTC| Business

SOUTH SAN FRANCISCO, Calif., Dec. 03, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with unmet medical needs in diseases that have...

STONEMOR SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against StoneMor Partners L.P. – STON

Dec 03, 2016 03:07 am UTC| Business

NEW ORLEANS, Dec. 02, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 20, 2017 to file lead plaintiff...

MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. – MYL

Dec 03, 2016 03:07 am UTC| Business

NEW ORLEANS, Dec. 02, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 12, 2016 to file lead plaintiff...

INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm

Dec 03, 2016 01:52 am UTC| Business

NEW YORK, Dec. 02, 2016 -- Stull, Stull Brody commenced a class action lawsuit against Arrowhead Pharmaceuticals, Inc. ("Arrowhead" or the "Company") (Nasdaq:ARWR) and its President and CEO Christopher R. Anzalone and...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ALXN

Dec 03, 2016 01:00 am UTC| Business

NEW YORK, Dec. 02, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. (“Alexion” or the “Company”) (NASDAQ:ALXN) and certain of its officers. The class...